GBS Inc. announced that until now, Steven Boyages has acted as both Chairman and interim Chief Executive Officer during this important transition phase. Given the growth and commercialization phase IBSS expects to enter. Steven Boyages will continue as Chairman of the Board and has reappointed Harry Simeonidis as Chief Executive Officer.

Mr. Simeonidis has more than 25 years of experience in healthcare, pharmaceutical and life sciences across various senior management positions throughout Asia, Australia, and New Zealand. Before joining Intelligent Bio Solutions, he was the General Manager, Surgery, Asia Pacific, at GE Healthcare where he oversaw significant expansion of the business' market share. Prior to this, Harry spent nine years as the President and CEO of GE Healthcare ANZ.

Mr. Simeonidis also served as non-executive Director of Farmaforce Limited.